Merck & Company Inc (MRK)vsNeurosense Therapeutics Ltd (NRSN)
MRK
Merck & Company Inc
$120.79
-3.46%
HEALTHCARE · Cap: $285.64B
NRSN
Neurosense Therapeutics Ltd
$0.75
-3.85%
HEALTHCARE · Cap: $29.23M
Smart Verdict
WallStSmart Research — data-driven comparison
MRK leads profitability with a 13.6% profit margin vs 0.0%. MRK earns a higher WallStSmart Score of 50/100 (D+).
MRK
Hold50
out of 100
Grade: D+
NRSN
Avoid16
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-49.3%
Fair Value
$80.88
Current Price
$120.79
$39.91 premium
Intrinsic value data unavailable for NRSN.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Strong operational efficiency at 38.6%
Generating 2.9B in free cash flow
Conservative balance sheet, low leverage
Areas to Watch
Premium valuation, high expectations priced in
4.9% revenue growth
Elevated debt levels
Weak financial health signals
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : NRSN
The strongest argument for NRSN centers on Debt/Equity.
Bear Case : MRK
The primary concerns for MRK are P/E Ratio, Revenue Growth, Debt/Equity.
Bear Case : NRSN
The primary concerns for NRSN are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
NRSN carries more volatility with a beta of 1.54 — expect wider price swings.
MRK is growing revenue faster at 4.9% — sustainability is the question.
MRK generates stronger free cash flow (2.9B), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - GENERAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MRK scores higher overall (50/100 vs 16/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Neurosense Therapeutics Ltd
HEALTHCARE · BIOTECHNOLOGY · USA
Neurosense Therapeutics Ltd (NRSN) is a forward-thinking clinical-stage biotechnology firm dedicated to revolutionizing treatments for neurodegenerative diseases, with a primary emphasis on Parkinson's disease. Utilizing its proprietary development platform, the company is advancing a promising pipeline of innovative therapeutic candidates that are currently under pivotal clinical trials, aimed at addressing critical unmet medical needs within the neurology domain. Backed by an experienced management team and strategic partnerships, Neurosense is positioned to deliver groundbreaking therapies that enhance patient outcomes and solidify its competitive standing in the biopharmaceutical industry.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?